Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Kushal T. Kadakia"'
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-4 (2024)
The U.S. Food and Drug Administration’s (FDA) recent authorization of DermaSensor, an AI-enabled device for skin cancer detection in primary care, marks a pivotal moment in digital health innovation. Clinically, the authorization of the first AI-en
Externí odkaz:
https://doaj.org/article/785d719fc36d43588abf1af92735782a
Autor:
Rutulkumar Patel, Daniel E. Cooper, Kushal T. Kadakia, Annamarie Allen, Likun Duan, Lixia Luo, Nerissa T. Williams, Xiaojing Liu, Jason W. Locasale, David G. Kirsch
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-14 (2024)
Abstract Diverse tumor metabolic phenotypes are influenced by the environment and genetic lesions. Whether these phenotypes extend to rhabdomyosarcoma (RMS) and how they might be leveraged to design new therapeutic approaches remains an open question
Externí odkaz:
https://doaj.org/article/0569329ceb654b2aad711245a321df14
Publikováno v:
Medical Devices: Evidence and Research. 16:111-122
Maryam Mooghali,1,2 Joseph S Ross,1â 4 Kushal T Kadakia,5 Sanket S Dhruva6,7 1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; 2Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale Schoo
Autor:
KUSHAL T. KADAKIA, SANDRO GALEA
Publikováno v:
The Milbank Quarterly. 101:153-175
Autor:
KUSHAL T. KADAKIA, ANAEZE C. OFFODILE
Publikováno v:
The Milbank Quarterly. 101:866-892
Autor:
KUSHAL T. KADAKIA, KAREN B. DESALVO
Publikováno v:
The Milbank Quarterly. 101:674-699
Autor:
Kushal T. Kadakia, Karen B. DeSalvo
Publikováno v:
American journal of public health. 111(S3)
Autor:
Kushal T. Kadakia, Vinay K. Rathi, Reshma Ramachandran, James L. Johnston, Joseph S. Ross, Sanket S. Dhruva
Publikováno v:
Nature Biotechnology. 41:607-609
Autor:
Kushal T, Kadakia, Celynne A, Balatbat, Albert L, Siu, I Glenn, Cohen, Consuelo H, Wilkins, Victor J, Dzau, Anaeze C, Offodile 2nd
Publikováno v:
The Milbank Quarterly. 100:673-701
Policy Points Hospital-at-Home (HaH) is a home-based alternative for acute care that has expanded significantly under COVID-19 regulatory flexibilities. The post-pandemic policy agenda for HaH will require consideration of multistakeholder perspectiv
Publikováno v:
Nature Medicine. 29:525-527